Question 1

What is the catalog number for Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%)?

Accepted Answer

The catalog number for Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%) is VAng-Cr3875-25kU.

Question 2

Is Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%) in stock?

Accepted Answer

Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 4

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%)

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

MCAM / MUC18 / Mucin 18 / CD146 (MCAM/1101), CF594 conjugate, 0.1mg/mL

Tenascin C (Stromal Marker For Epithelial Malignancy) (TNC/2981R), CF488A conjugate, 0.1mg/mL

HSV1 (Herpes Simplex Virus Type I) ICP8 (HSVI/2045), CF740 conjugate, 0.1mg/mL

Bcl-2 (BCL2/796), 0.2mg/mL

Anti-TNF alpha Antibody Picoband® (Biotine Conjugate)

Lactoylglutathione Lyase (CPTC-GLO1-3), CF594 conjugate, 0.1mg/mL